Omnicom Group
OMC
$80.83
+2.84%
Omnicom Group Inc. is a holding company that owns a portfolio of advertising agencies and related firms, providing traditional and digital advertising services including creative design, market research, data analytics, ad placement, and public relations across more than 70 countries. As one of the world's largest advertising conglomerates, it competes with peers like WPP and Publicis, with a strong presence in North America (over half of revenue) and Europe (nearly 30%). The current investor narrative centers on the company's ability to navigate a rapidly evolving digital advertising landscape and its recent financial performance, which has been marked by a significant impairment-driven loss in Q4 2025, raising questions about underlying growth and margin stability. Recent news highlights a maintained dividend, underscoring its appeal as an income stock, while analyst actions show mixed sentiment with some upgrades and one downgrade.…
OMC
Omnicom Group
$80.83
Related headlines
Investment Opinion: Should I buy OMC Today?
Rating: Hold. The thesis is that Omnicom's low valuation and strong cash flow provide a margin of safety, but the recent impairment and mixed analyst sentiment warrant caution until organic growth and margin trends improve. The consensus analyst rating is Buy with an average target price of ~$106.50, implying 35% upside, but limited coverage and one downgrade temper conviction. Supporting evidence includes: (1) trailing PS of 0.94x vs. industry average 1.5x, a 37% discount; (2) Q4 2025 revenue growth of 27.9% YoY, though acquisition-driven; (3) free cash flow of $2.79B supporting a 3.37% dividend yield; and (4) forward PE of 6.44x based on estimated EPS of $16.54, which is low relative to historical averages. Risks that could invalidate the thesis: (1) further impairment charges eroding book value and earnings; (2) organic revenue growth decelerating below 5% as acquisition benefits fade; (3) dividend cut if cash flow deteriorates. The rating would upgrade to Buy if the stock pulls back to $70 (near 52-week low) or if organic growth accelerates above 10%. It would downgrade to Sell if another impairment exceeds $500M or if free cash flow drops below $1.5B. Overall, Omnicom appears undervalued relative to its history and peers, but the impairment overhang and low coverage keep it a Hold for now.
Sign up to view all
OMC 12-Month Price Forecast
Omnicom's valuation is compelling on a historical and peer basis, but the $1.9B impairment and mixed analyst sentiment create uncertainty. The base case of modest growth and stable margins is most likely, with a 50% probability. The bull case depends on successful integration and organic acceleration, while the bear case hinges on further impairments or macro weakness. The neutral stance reflects the balanced risk/reward: the stock is cheap but faces real headwinds. An upgrade to bullish would require clear evidence of organic growth and margin expansion, while a downgrade to bearish would follow another impairment or dividend cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Omnicom Group's 12-month outlook, with a consensus price target around $105.08 and implied upside of +30.0% versus the current price.
Average Target
$105.08
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$65 - $105
Analyst target range
Only 4 analysts cover Omnicom, which is relatively low for a large-cap stock, indicating limited institutional interest. The consensus recommendation is a Buy, with an average estimated EPS of $16.54 for the next fiscal year. The average revenue estimate is $27.24 billion, implying a forward PS of 0.60x. The estimated EPS range is $16.06 to $17.06, suggesting a tight spread and relatively high conviction among the few analysts. The average target price is not explicitly provided, but based on the forward PE of 6.44x and estimated EPS of $16.54, the implied target price is approximately $106.50, representing 35% upside from the current price of $78.62. However, this calculation assumes the forward PE is based on the current price, which may not be accurate. The low target of $16.06 EPS implies a price of $103.40 (using the same PE), while the high target of $17.06 EPS implies $109.90. The recent ratings show a mix: UBS and Citigroup maintain Buy ratings, Barclays holds at Equal Weight, and B of A Securities downgraded to Underperform in January 2026. This divergence suggests uncertainty about the company's near-term prospects, particularly after the impairment charge. The wide range of opinions and limited coverage imply higher volatility and less efficient price discovery for the stock.
Drowning in data?
Find the real signal!
Bulls vs Bears: OMC Investment Factors
Omnicom presents a classic value vs. value trap debate. On the bull side, the stock trades at historically low multiples (PS 0.94x, PB 1.35x) with strong free cash flow ($2.79B) and a 35% upside to analyst targets. The acquisition-driven revenue growth (27.9% YoY) could accelerate digital transformation. However, the bear case highlights the $1.9B impairment that wiped out earnings, a current ratio below 1.0, and persistent market underperformance. The single most important tension is whether the impairment is a one-time event or a signal of deeper issues with acquisition strategy. If the company can demonstrate organic growth and margin stability, the low valuation could re-rate significantly. If further impairments or revenue deceleration occur, the stock could test its 52-week low of $66.33. Currently, the evidence slightly favors the bull case given the valuation discount and cash flow strength, but the risk is elevated.
Bullish
- Strong Revenue Growth from Acquisition: Q4 2025 revenue surged 27.9% YoY to $5.53 billion, driven by the Flywheel digital commerce acquisition. This positions Omnicom to capture high-growth digital advertising segments and diversify beyond traditional agency services.
- Robust Free Cash Flow Generation: Trailing twelve-month free cash flow stands at $2.79 billion, providing ample liquidity for dividends, debt reduction, and strategic investments. The dividend yield of 3.37% is well-covered by cash flows.
- Attractive Valuation vs. Peers and History: The trailing PS ratio of 0.94x is a 37% discount to the industry average of 1.5x and near historical lows. The PB ratio of 1.35x is also near the bottom of its 5-year range of 3.1x-6.1x, suggesting potential value.
- Analyst Consensus Buy with 35% Upside: The average analyst EPS estimate of $16.54 implies a forward PE of 6.44x, translating to a target price of ~$106.50, representing 35% upside from the current $78.62. This suggests the market is undervaluing normalized earnings.
Bearish
- Massive Impairment Charge Wiped Out Earnings: Q4 2025 included a $1.9 billion impairment charge, swinging net income to a -$941 million loss from a $448 million profit a year ago. This raises concerns about acquisition discipline and the true value of acquired assets.
- Low Analyst Coverage and Mixed Sentiment: Only 4 analysts cover the stock, with one downgrade (BofA to Underperform) and mixed ratings. Limited coverage can lead to inefficient price discovery and higher volatility.
- Liquidity Concerns from Current Ratio: The current ratio of 0.93 indicates current liabilities exceed current assets, which could pressure short-term financial flexibility if cash flows weaken.
- Underperformance vs. Market and Peers: The stock's 1-year return of +4.8% significantly lags the S&P 500's +19.1%, and relative strength over 1 year is -14.3%. This persistent underperformance may reflect structural challenges in the advertising industry.
OMC Technical Analysis
The stock is in a range-bound consolidation pattern over the past year, with a 1-year price change of +4.8% significantly underperforming the S&P 500's +19.1% gain. Currently trading at $78.62, the stock sits at 72% of its 52-week range ($66.33 low to $87.17 high), indicating it is closer to the lower end of the range after a sharp decline from the highs. This positioning suggests the stock is not in a strong uptrend but may be viewed as a value opportunity if fundamentals support a recovery, though the relative weakness versus the market is notable. The 1-month price change of +4.52% shows a short-term bounce, while the 3-month change of +5.09% indicates a modest recovery from the lows. However, the 6-month change of -3.32% and year-to-date change of -3.32% reveal that the stock has been under pressure over the medium term. The 1-month relative strength of +5.77 versus the S&P 500 suggests recent outperformance, but the 1-year relative strength of -14.30 confirms a prolonged period of underperformance. The 52-week low of $66.33 and high of $87.17 define the trading range. A breakout above $87.17 would signal a potential trend reversal and renewed bullish momentum, while a breakdown below $66.33 could indicate further downside risk. The beta of 0.656 indicates the stock is less volatile than the market, which may appeal to risk-averse investors but also limits upside participation in strong market rallies.
Beta
0.66
0.66x market volatility
Max Drawdown
-18.7%
Largest decline past year
52-Week Range
$66-$87
Price range past year
Annual Return
+11.5%
Cumulative gain past year
| Period | OMC Return | S&P 500 |
|---|---|---|
| 1m | +6.9% | +2.0% |
| 3m | +8.1% | +10.6% |
| 6m | +2.2% | +8.3% |
| 1y | +11.5% | +20.4% |
| ytd | -0.6% | +10.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OMC Fundamental Analysis
Revenue has shown strong growth in the most recent quarter, with Q4 2025 revenue of $5.53 billion representing a 27.9% year-over-year increase, driven by a 27.9% YoY growth rate. However, this growth was heavily influenced by a large acquisition (likely the Flywheel digital commerce business), as organic growth may be lower. The trailing twelve-month revenue run-rate is approximately $17.3 billion, with the advertising segment contributing $3.32 billion (60% of Q4 revenue), followed by public relations ($501 million), healthcare ($410 million), and experiential ($360 million). The company swung to a net loss of -$941 million in Q4 2025 from a profit of $448 million in Q4 2024, primarily due to a $1.9 billion impairment charge (total other income/expenses net of -$1.9 billion). Excluding this charge, operating income was $876 million, implying an operating margin of 15.8%, down from 16.2% in Q4 2024. Gross margin improved slightly to 17.8% from 18.5% in the prior year quarter, but the net margin turned deeply negative at -17.0% due to the impairment. The company's balance sheet shows a debt-to-equity ratio of 1.06, which is manageable but elevated. Free cash flow for the trailing twelve months was $2.79 billion, a strong figure that supports the dividend and debt service. However, the current ratio of 0.93 indicates potential liquidity concerns, as current liabilities exceed current assets. ROE was negative at -0.45% due to the net loss, but normalized ROE would be in the mid-teens based on operating income.
Quarterly Revenue
$5.5B
2025-12
Revenue YoY Growth
+27.92%
YoY Comparison
Gross Margin
17.79%
Latest Quarter
Free Cash Flow
$2.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OMC Overvalued?
Since net income is negative (trailing EPS of -$4.02), the trailing PE ratio is not meaningful. Therefore, we use the price-to-sales (PS) ratio as the primary valuation metric. The trailing PS ratio is 0.94x, while the forward PS ratio (based on estimated revenue of $27.24 billion) is approximately 0.60x, implying the market expects significant revenue growth. The EV/Sales multiple of 1.54x is also modest. Compared to the advertising industry average PS ratio of approximately 1.5x (based on sector data), Omnicom trades at a 37% discount, suggesting the market is pricing in lower growth or higher risk. The PEG ratio of 2.89x indicates that the stock is not cheap on a growth-adjusted basis if earnings normalize. Historically, the stock's PS ratio has ranged from about 3.0x to 5.5x over the past five years, with the current 0.94x near the bottom of that range. This low multiple reflects the recent impairment and earnings volatility, but could also present a value opportunity if the company returns to profitability and growth. The PB ratio of 1.35x is also near historical lows (historical range 3.1x to 6.1x), further supporting the value thesis.
PE
-299.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -4x~26x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
26.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is the $1.9 billion impairment charge in Q4 2025, which caused a net loss of -$941 million and a negative trailing EPS of -$4.02. This impairment suggests that prior acquisitions may not be yielding expected returns, and further write-downs could occur. The debt-to-equity ratio of 1.06 is manageable but elevated, and the current ratio of 0.93 indicates that current liabilities exceed current assets, posing liquidity risk if cash flows decline. Additionally, operating margin slipped to 15.8% in Q4 2025 from 16.2% a year ago, indicating margin pressure despite revenue growth. Market & Competitive Risks: Omnicom trades at a PS ratio of 0.94x, a 37% discount to the industry average, which could reflect the market's skepticism about growth sustainability. The stock's beta of 0.656 suggests lower volatility but also limited upside participation in market rallies. Competitive risks include the rapid shift to digital advertising and the rise of in-house agencies and tech platforms (e.g., Google, Meta) that bypass traditional agencies. Regulatory risks around data privacy could also impact targeted advertising capabilities. The recent downgrade by BofA Securities to Underperform highlights analyst concerns about near-term prospects. Worst-Case Scenario: If Omnicom reports further impairments, organic revenue growth stalls, or the advertising market enters a downturn, the stock could fall to its 52-week low of $66.33, representing a 15.6% decline from the current price of $78.62. In a severe recession, the stock could drop further to $60, a 23.7% loss, based on historical max drawdown of 18.66% and potential multiple compression.
FAQ
The primary risk is further impairment charges, as the $1.9B write-down in Q4 2025 indicates potential overpayment for acquisitions. Financial risk includes a current ratio of 0.93, meaning current liabilities exceed current assets, which could strain liquidity. Competitive risk comes from digital giants like Google and Meta that bypass traditional agencies, and from peers like Publicis that are investing heavily in data and tech. Macro risk is significant: a recession could reduce ad spending, and the stock's beta of 0.656 offers some protection but limits upside. Company-specific risk includes the low analyst coverage (only 4 analysts), which can lead to volatile price movements on news. The most severe risk is a dividend cut if free cash flow deteriorates, which would undermine the income thesis.
The 12-month outlook is balanced among three scenarios. The base case (50% probability) sees the stock trading in a range of $80-$95, with modest revenue growth and stable margins. The bull case (25% probability) targets $95-$110, driven by successful integration of Flywheel and organic growth acceleration. The bear case (25% probability) sees the stock falling to $66-$78, potentially testing the 52-week low of $66.33, if further impairments or a recession hit. Analyst estimates imply a forward PE of 6.44x and an average target of ~$106.50, but this is based on only 4 analysts. The most likely scenario is the base case, assuming no major negative surprises. Investors should monitor organic growth and margin trends in upcoming quarters.
Based on price-to-sales, Omnicom appears undervalued. The trailing PS ratio of 0.94x is well below the industry average of 1.5x and near the bottom of its historical range (3.0x-5.5x over five years). The PB ratio of 1.35x is also near historical lows (range 3.1x-6.1x). However, the trailing PE is negative due to the impairment, making it uninformative. On a forward basis, using estimated EPS of $16.54, the forward PE is 6.44x, which is low but reflects the market's skepticism about earnings quality. The PEG ratio of 2.89x suggests the stock is not cheap on a growth-adjusted basis if earnings normalize. Overall, the market is pricing in significant risk, making OMC a potential value play if the company can avoid further impairments and deliver steady growth.
Omnicom offers a compelling value proposition with a trailing PS ratio of 0.94x, a 37% discount to the industry average, and a 3.37% dividend yield supported by $2.79B in free cash flow. Analyst consensus is Buy with an average target of ~$106.50, implying 35% upside. However, the stock carries significant risk from the $1.9B impairment in Q4 2025, which caused a net loss and negative EPS. The mixed analyst sentiment (one downgrade) and low coverage (only 4 analysts) add uncertainty. For income-oriented investors with a long-term horizon, OMC could be a good buy at current levels, but growth investors may find better opportunities elsewhere. The stock is best suited for those who can tolerate potential near-term volatility in exchange for a cheap valuation and reliable dividend.
Omnicom is better suited for long-term investment, particularly for income-focused investors. The stock's beta of 0.656 indicates lower volatility, making it less attractive for short-term trading. The 3.37% dividend yield and strong free cash flow provide a steady income stream, while the low valuation offers potential for capital appreciation over time. However, the recent impairment and mixed analyst sentiment could cause near-term price swings. A minimum holding period of 3-5 years is recommended to allow the company to integrate acquisitions and demonstrate consistent earnings growth. Short-term traders may find limited upside given the stock's range-bound behavior and low relative strength versus the market.
